Category Archives: Epidiolex

DEA reschedules epilepsy drug derived from marijuana

Epidiolex liquid CBD tincture. (Image from GW Pharma) A drug approved by the U.S. Food and Drug Administration (FDA) containing an ingredient found in cannabis will be reclassified for medical use. The Drug Enforcement Administration on Thursday placed the marijuana-derived drug Epidiolex in Schedule V of the Controlled Substances Act, reports CNBC. Epidiolex contains cannabidiol […]

FAQ: What to Know About the DEA’s CBD Rescheduling Order

For the first time ever, the Drug Enforcement Agency this week removed a cannabis-derived drug from Schedule I of the Controlled Substances Act. The change is a historic landmark on the path to ending cannabis prohibition, but it’s not nearly as sweeping as it might seem. RELATED STORY US Reschedules CBD Drug—but Not CBD Itself […]